Your browser doesn't support javascript.
Neutralizing Antibodies Against SARS-CoV-2 Variants After Infection and Vaccination.
Edara, Venkata Viswanadh; Hudson, William H; Xie, Xuping; Ahmed, Rafi; Suthar, Mehul S.
  • Edara VV; Emory University Department of Pediatrics, Atlanta, Georgia.
  • Hudson WH; Emory Vaccine Center, Atlanta, Georgia.
  • Xie X; University of Texas Medical Branch, Galveston.
  • Ahmed R; Emory Vaccine Center, Atlanta, Georgia.
  • Suthar MS; Emory University Department of Pediatrics, Atlanta, Georgia.
JAMA ; 325(18): 1896-1898, 2021 05 11.
Article in English | MEDLINE | ID: covidwho-1239960
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antibodies, Neutralizing / COVID-19 Vaccines / SARS-CoV-2 / COVID-19 / Antibodies, Viral Topics: Vaccines / Variants Limits: Humans Language: English Journal: JAMA Year: 2021 Document Type: Article Affiliation country: Jama.2021.4388

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antibodies, Neutralizing / COVID-19 Vaccines / SARS-CoV-2 / COVID-19 / Antibodies, Viral Topics: Vaccines / Variants Limits: Humans Language: English Journal: JAMA Year: 2021 Document Type: Article Affiliation country: Jama.2021.4388